Table 3.
SpeG ligand-free form/complex with spermine | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Concentration, mg/mL | 0.45 | 0.9 | 1.8 | 3.6 | 7.2 | |||||
Structural parameters: | free | complex | free | complex | free | complex | free | complex | free | complex |
I(0) (cm−1) [from P(r)] | 0.043 | 0.197 | 0.072 | 0.196 | 0.099 | 0.196 | 0.123 | 0.197 | 0.144 | 0.196 |
Rg (Å) [from P(r)] | 35 | 45.5 | 36.7 | 42.4 | 38.5 | 42.4 | 39.7 | 42.4 | 40.6 | 42.1 |
I(0) (cm−1) (from Guinier plot) | 0.066 | 0.199 | 0.085 | 0.199 | 0.109 | 0.199 | 0.132 | 0.201 | 0.144 | 0.197 |
Rg (Å) (from Guinier plot) | 34.2 | 43.4 | 36.4 | 43.4 | 38.6 | 43.7 | 39.6 | 43.7 | 39.9 | 43.0 |
Dmax (Å) | 117.7 | 147.9 | 125.9 | 140.8 | 131.1 | 134.5 | 131.4 | 125.5 | 139.4 | 121.7 |
Porod volume estimate (nm3) | 135 | 436 | 196 | 445 | 245 | 448 | 287 | 455 | 321 | 448 |
Volume of correlation (Å3) | 537 | 1128 | 660 | 1136 | 769 | 1139 | 851 | 1145 | 909 | 1128 |
Molecular-mass determination: | ||||||||||
Molecular mass Mr [Vc2/(.1231×Rg)] (kD) | 68.5 | 239 | 97.5 | 241 | 124 | 241 | 149 | 244 | 168 | 240 |
Calculated monomeric Mr from sequence (kD) | 20.7 |